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Background & aims: As far as we know, no screening questionnaire has been developed and
validated for identification of adverse food reactions in Portuguese-speaking adults, as an initial
approach towards the investigation of cases of possible food allergy. Thus, the objective of this
study was to develop and validate a screening questionnaire of food allergy in adult Portuguese-
speaking patients.
Methods: This was a multicentre, cross-sectional study using a simple random sample of 186
adults between 18 and 82 years old from various parts of the centre of Portugal. Intelligibility of
the questionnaire was first assessed in 24 patients with confirmed IgE- or non-IgE-mediated food
allergy, and in 24 volunteers without food allergies. The 17-item questionnaire was subsequently
applied by phone to 78 food allergic patients (66 IgE-mediated and 12 non-IgE mediated) and to
60 non-food allergic volunteers, with subsequent reassessment (re-test). Face and content validity,
intelligibility, construct validity, and test-retest reliability (temporal stability) were analysed.
Results: Face and content validity allowed item reduction from 30 to 17 items with adequate
content validity index >0.78. Construct validity was confirmed in the 66 confirmed IgE-mediated
food allergic patients, 12 non-IgE-mediated food allergic patients, and 60 non-allergic patients.
Test-Retest Reliability (general temporal stability) of the test had a Spearman correlation coeffi-
cient value of 0.845 for the retest. Cohen's Kappa values for the relevant questions were greater
than 0.890 for almost all items. No differences were found when sex, age, and volunteers'
recruitment origin were analysed. An inverse relationship was found between reliability and retest
time interval.
Conclusions: Due to the quick and easy implementation, confirmation of face, content and
construct validity as well as high temporal reproducibility, this screening questionnaire may be a
useful study tool for an initial approach to detection of food allergies in adults.
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Food allergy is an important health problem in
western countries as reflected in the appearance of
numerous publications in this field over the past
years.1 For instance, in the United States, up to 20%
of the population has been shown to change their
diet due to the development of food allergy or
other type of adverse reaction to food.2
Nevertheless, the values for the prevalence of food
allergy in the general population, particularly in
adults, are not well known. In fact, various meta-
analyses3–5 and other recent studies6,7 estimate
that the prevalence of food allergy may vary
according to the methodology used: 6–13% of
adults and 6–38% of children when based upon
self-reports, and 1–3% at all ages when oral food
challenges are performed. Independently of using
or not other diagnostic tests, namely oral provoca-
tion procedures, most studies on the prevalence of
food allergies in the general population have been
based upon an initial step involving the application
of a questionnaire, whichmust be validated in order
to be useful in terms of analysis.8–12
Thus far, only one studyon theprevalenceof food
allergies in the general population has been per-
formed in Portugal, limited to a sample of 659 adult
participants older than 39 years old, where the au-
thors performed a large, health and nutrition
questionnaire, including questions not only related
with food allergy, but also to demographic charac-
teristics and social dietary habits.13 Furthermore, as
far as we know, no validated questionnaires, or
clinical history screening questionnaires for
epidemiological studies of adverse food reactions
(AFR) as an initial approach to the study of food
allergies in adults have been developed in
Portuguese speaking countries. In fact, there is a
lack of validated questionnaires or other clinical
screening tools for the study of food allergies in
adults, worldwide. Therefore, this is a pilot study,
aimed at developing a clinical history screening
questionnaire to be specifically applied in adults
and studying its validity and reliability.MATERIALS AND METHODS
Setting
This study was carried out at 3 healthcare cen-
tres in the central region of Portugal and at theallergy outpatient clinics of the central hospitals of
Castelo Branco Local Health Unit and Cova da
Beira University Hospital Centre, serving a popu-
lation of 180,000 inhabitants older than 15 years
old.14 It was carried out between 2012 and 2015.
Volunteers and study design
Overall, we studied 186 volunteers, as shown in
the Fig. 1 flowchart. Initially, we recruited 4 groups
of adult volunteers into 2 clusters with
characteristics similar to those of subjects in
whom a future study on food allergy will be
carried out. The first cluster (“Intelligibility study
groups-ISG”) was formed by 2 groups of
individuals: a series of 24 non-food allergic vol-
unteers from the general population (randomly
recruited from general practicioners’ files of
participating healthcare centres and other hospital
clinical services doctors files), and another series of
24 randomly recruited patients with food allergy
confirmed by clinical history, specific IgE levels,
cutaneous tests, and double-blind placebo-
controlled food challenges (DBPCFC) (patients
with IgE-mediated food allergy), with 2 of them
being patients with positive clinical history and
DBPCFC but negative specific IgE levels and
cutaneous tests (patients with non-IgE-mediated
food allergy), belonging to a database of food
allergic patients, prepared from the medical re-
cords of the allergy outpatient clinics of the central
hospital of the Castelo Branco Local Health Unit
and Cova da Beira University Hospital Centre. This
intelligibility study group was used for piloting
purposes.
The second cluster of volunteers (case patients
and control individuals) was different from the ISG
groups, and was used for validity testing, namely
test-re-testing, and included a total of 138 volun-
teers. This cluster included 66 randomly recruited
adult patients with IgE-mediated food allergies,
not previously selected for the first cluster,
confirmed according to the same protocol used
for the ISG patient group (clinical history, specific
IgE levels, cutaneous tests and DBPCFC). Patients
were randomly recruited from the previously
mentioned database of food allergic patients of
the Allergy Outpatient Clinic of the Castelo Branco
Local Health Unit and Cova da Beira University
Hospital Centre (“Case Group-IgE”). An extra
group of 12 patients with positive DBPCFC but
Fig. 1 Flowchart of study methodology steps
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recruited from the same database, and these pa-
tients constituted a non-IgE-mediated food allergy
group. Non-food allergic volunteers (n ¼ 60) from
the general population were also randomly
selected from the files of general practitioners
belonging to the participating healthcare centres
and who were invited to take part in the study
(“Control Group”).Development of the clinical screening
questionnaire
The initial step consisted of a bibliographical
search for published validated questionnaires for
screening food allergies in adults and was per-
formed on PubMed using terms such as “ques-
tionnaire”, “survey”, “food allergy”, “food
hypersensitivity”, “history”, “tool”, and “diagnosis”.
Published reports, namely EuroPrevall studies, did
not include full questionnaires or did not mention
any validation data. In addition, possible cultural
adaptations might be needed. Although interna-
tional consensus agrees that the allergy-focused
history is a key part of the diagnostic pathway,
there is no agreement regarding the type of
questions to be asked, or the typified clinical his-
tory, as highlighted by Skypala et al.15 For these
reasons, we decided to develop a clinical historyscreening questionnaire for our study. Its design
was based upon specific principles, as defined
by a panel of experts in line with principles
previously used in other publications using
questionnaires in other fields of study,16–18 as
well as taking into account Portuguese19 and
European guidelines.20 It was also based upon a
questionnaire previously applied to children with
food allergies,21 with an adequate sample size
calculated in accordance with appropriate
recommendations.22,23 The questionnaire aimed
at screening for the presence of adverse food
reactions and their risk factors. It also included
the main clinical manifestations of adverse
reactions to foods which are crucial to its
diagnosis, as well as demographic data such as
age, gender, and healthcare centre of referral.
The questions were designed in an objective way
in 7 domains, in a procedure similar to that used
in a questionnaire developed and validated by
our group, for detecting children with food
allergies.24 The first questions focused on the
identification of the volunteer (assigning an
identification code for data anonymisation,
gender, and age) and request to answer the
questionnaire (questions 1–4). In addition, item
17, asked volunteers about willingness to carry
out a food allergy study in a specialized centre.
Domain #1 focused on confirmation of the
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(item 5). We must stress that the questionnaire
only proceeded on from this point in case of a
positive answer to this question. Domain #2
aimed at identifying the food which triggered the
adverse reaction (question 6). Domain #3
focused on characterisation of the reaction to
suspect food(s), and included questions 7 and 8.
These questions were answered separately for
each identified trigger food, and they included
evaluation of reported symptoms and their
severity, as well as definition of the reaction as
immediate or delayed. Domain #4 included
questions 9 and 10 and asked the need for
treatment and procedures followed in response
to the reaction. Domain #5 involved questions
about previous reactions and how long ago the
last reaction had taken place (items 11 and 12).
Domain #6 studied the accessibility to diagnosis
of food allergy, focusing as well on medical
specialty care versus general practitioner care
(questions 13 and 14). Domain #7 included
questions 15 and 16, on personal and family
history of allergy, as risk factors.Analysis of theoretical construct: face and content
validity
This initial version was analysed by a panel of 3
medical experts with experience in food allergy,
who checked the questionnaire in terms of face
validity, bearing in mind food allergy concepts and
guidelines (Table 1). Analysis of content validity
was performed by submitting the questionnaire
for review to a team of nine medical specialists in
allergy with recognized clinical and research
experience in food allergy, who rated the
relevance of each question in terms of current
guidelines and knowledge (1-not relevant; 2-
somewhat relevant; 3-quite relevant; 4-highly
relevant).25 The Item Content Validity Index (I-
CVI) was calculated for each question, as the
number of experts that gave a rating of 3 or 4,
divided by the total number of experts, and I-CVI
was regarded as significant if its value was 0.78
or above 26(Table 1). In addition, the experts also
suggested modifications deemed as relevant,
proposed the inclusion of new aspects and
reviewed semantics as well, in a procedure
similar to that previously performed by Lyra
et al.21 The questionnaire was then convertedinto a Google Docs format in order to facilitate
collection of data via a phone call.Logical (intelligibility) analysis of the
questionnaire
In order to assess its intelligibility, adequacy,
logic, and comprehension of the questions and
duration, as well as the eventual need to modify
some of the terms for the sake of clarity and
adequate data collection, a pilot study was per-
formed, with the questionnaire being applied to
the 2 volunteer groups, matched in terms of so-
cioeconomic status and degree of literacy (“Intel-
ligibility study groups-ISG”). In 50% of cases, the
questionnaire was applied by phone, and in the
other 50% it was applied in a written form. Time
taken to complete the questionnaire was
measured in both groups. In addition, these vol-
unteers were asked for an opinion about the de-
gree of difficulty and pertinence of the
questionnaire items. With the feedback obtained,
some of the questions were simplified.
Subsequently, the questionnaire was again sent
to a panel of 3 allergists with experience in food
allergy, who agreed upon the final version of the
questionnaire. Thus, literature review, allergy ex-
perts, and non-food allergic volunteers as well as
patients with DBPCFC-confirmed food allergy
contributed to content validity of the
questionnaire.Analysis of empirical construct: construct validity
In order to assess construct validity, the 17-item
questionnaire was analysed in terms of known-
group validity. We specifically wanted to test our
hypotheses that the test would discriminate be-
tween: a) food allergic patients and non-food
allergic individuals; b) IgE-mediated and non-IgE-
mediated food allergic patients. Known-group
validity analysis was based on analysis of the
agreement between positive replies to its ques-
tions and the actual presence of food allergy in
patients with previously confirmed food allergy
(positive food-specific skin tests, positive food
allergen-specific IgE, and positive DBPCFC), as
well as differences in replies between patients with
IgE-mediated and non-IgE-mediated food
allergy.22
Question number Item Item CVI
1 Identity Code of volunteer 1
3 Gender 0.888
3 Age in years 0.888
4 Do you want to answer this questionnaire? 1
5 Ethnicity 0.222
6 Social grade (occupation) 0.111
7 Literacy 0.111
8 Do you have any systemic disease? 0.111
9 Do you have any adverse food reaction? 1
10 What kind of food causes your reaction? 1
11 How much food caused the reaction? 0.333
12 Was the food that caused the reaction cooked (or
not)?
0.222
13 What kind of reaction did you have? 1
14 Where did you have the reaction? 0.111
15 How long after food ingestion did the reactions
appear?
0.888
16 Did you need medical treatment? 1
17 If answer was “yes” for item 9, Where did you
receive medical treatment?
0.888
18 What kind of treatment did you receive
(intravenous, oral)?
0.333
19 Did food ingestion occur on an empty stomach? 0.111
20 Was food ingestion associated with exercise? 0.222
21 Was food ingestion associated with any drug
treatment?
0.111
22 Did you drink alcohol beverages during food
ingestion?
0.222
23 Have you had any previous episodes with the same
food?
1
24 How long ago did the previous reaction take
place?
1
25 Have you had subsequent episodes with the same
food?
0.333
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Question number Item Item CVI
27 Have you ever been to a specialty appointment by
an Allergist doctor?
1
28 Do you have any other allergic disease? (personal
history of atopy)
1
29 Does anybody in your family have an allergic
disease?
0.888
30 Would you want to be followed up at a specialty
clinic?
1
Table 1. (Continued) Initial 30 items screening questionnaire and Item Content Validity Index (I-CVI) average performed by the nine experts
medical specialists in allergy. Italic: Items deleted in final versionItems highlighted in bold had a high I-CVI score (high level of concordance among
experts).
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questionnaire
The questionnaire was analysed in terms of
reliability, using a test-retest approach. The ques-
tionnaire was applied via a phone call by a trained
technician under allergist supervision, to the case
and control groups as previously defined in the
“volunteers” section and re-applied via a phone
call to the case and control groups, on a second
contact (“test-retest” technique)22 after the first
phone call.
Statistical analysis
Spearman's correlation coefficient (Spearman's
Rho value) was used for determination of temporal
stability, regarding values > 0.70 in absolute value
as a strong correlation.
Analysis of concordance and reproducibility of
the questionnaire was performed using Cohen's
Kappa Test for each question. Cohen's Kappa re-
sults and their 95% confidence intervals were
accepted as having good concordance if Kappa
values were >0.60, and as having almost perfect
concordance for levels of Kappa >0.80.22 Data
were studied using SPSS 22.0 (SPSS Inc.,
Chicago, IL, USA).27 A level of significance of less
than 0.05 was regarded as statistically significant.
Ethical aspects
This study was conducted in accordance with
the guidelines laid down in the Declaration of
Helsinki, and all procedures involving subjects/
patients were approved by the Ethics Committees
of the Amato Lusitano Hospital (Castelo BrancoLocal Health Unit), the Cova da Beira University
Hospital Centre, and the Sub-Regional Health Au-
thorities of Castelo Branco. Written informed con-
sent was obtained from all subjects/patients.
RESULTS
Face and content validity
From the initial 30 questions, only 17 were kept
(Table 2), with 0.967 being the final mean of the I-
CVIs for the 17 scale items (mean I-CVI). These 17
items were regarded as essential for obtaining
adequate information from the patients
(Supplementary Material 1), and distributed by 7
domains.
Demographics of the study volunteers
Intelligibility study groups-ISG (pilot testing)
The 24 non-food allergic volunteers included in
the “ISG-NFA” group were randomly recruited
from the medical files of general population
registed at participating primary care centres (50%
females, median age of 45  7 years). The 24
volunteers with confirmed food allergy (positive
clinical history, specific IgE, skin tests, DBPCFC),
randomly recruited from the Allergy outpatient
clinics belonging to both hospitals (83% females,
median age of 36  11 years), were included in the
“ISG-FA” group. These 2 groups were matched in
terms of age, gender, Graffar scale, and degree of
literacy.
Case and controls groups (validation testing)
The 66 patients with previously confirmed
(positive clinical history, specific IgE, skin tests, and
Question
number Item References
1 Identity Code of volunteer 19
3 Gender 9,10,12,18,19,21,31,32,39
3 Age in years 9–12,18,19,21,31,32,39
4 Do you want to answer this questionnaire? 9,10
5 Do you have any adverse food reaction? 9,10,12,18,19,21,31,32
6 What kind of food causes your reaction? 9,10–12,18–21,31,32,39,41
7 What kind of reaction did you have? 9–12,19–21,31,32,39–41
8 How long after food ingestion did the reactions appear? 9,10,12,19–21,31,39–41
9 Did you need medical treatment? 10,21,31,41
10 If answer was “yes” for item 9, Where did you receive
medical treatment?
10,31
11 Have you had any previous episodes with the same food? 20,21,39,41
12 How long ago did the previous reaction take place? 10,20,21,39,41
13 Have you been previously diagnosed with food allergy? 10,11,31
14 Have you ever been to a specialty appointment by an
Allergist doctor?
10,11,31
15 Do you have any other allergic disease? (personal history
of atopy)
9–12,18,20,21,31,39,41
16 Does anybody in your family have an allergic disease? 9,10,11,20,40,41
17 Would you want to be followed up at a specialty clinic? 9,10
Table 2. Screening questionnaire and references used in its design
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and 74 years (mean ¼ 38.27  9.3 years; 73% fe-
male). Forty-six of these patients reported symp-
toms related to one single foodstuff, and the other
20 were sensitised to more than one food. Impli-
cated foodstuffs were seafood (32 cases), fresh
fruits (26 cases), tree nuts (11 cases), peanut (8
cases), vegetables, chicken and egg (4 cases
each), and other foodstuffs (8 cases). The 12 pa-
tients with previously confirmed (positive clinical
history and DBPCFC, but negative specific IgE and
skin tests) non-IgE mediated food allergies were
aged between 27 and 68 years
(mean ¼ 46.58  11.5 years; 67% female). Seventy-
five percent of these patients reported symptoms
related to one single foodstuff, and the other 25%
were sensitised to more than one food. Implicatedfoodstuffs were seafood (11 cases), fresh fruits (2
cases), and other foodstuffs (8 cases). The 60 non-
food allergic volunteers recruited from the general
population were aged between 18 and 82 years
(mean ¼ 50  14.21 years; 55% female). These 3
groups were matched in terms of age, gender,
Graffar scale, and degree of literacy.
Intelligibility and testing of the questionnaire
All volunteers in the ISG-NFA and ISG-FA
groups confirmed the intelligibility and adequacy
of the 17 questionnaire items. It was estimated that
the questionnaire, when applied to volunteers
without AFR, would take 1 min to complete for the
written form, and 2 min for the phone-applied
form. In case of food allergy-confirmed volun-
teers, it took between 2 and 10 min (mean of
8 Lozoya-Ibáñez et al. World Allergy Organization Journal (2020) 13:100456
http://doi.org/10.1016/j.waojou.2020.1004564.5  1.5 min), for the written form and 2 min for
the phone-applied form, respectively.Analysis of empirical construct: construct validity
The 17-item questionnaire was analysed in
terms of known-group validity in 3 different
groups: a) a group of 66 patients with previously
confirmed IgE-mediated food allergy, b) a group
of 12 patients with previously confirmed non IgE-
mediated food allergy, and c) a group of 60 non-
food allergic volunteers.
Questionnaire items 5 (main), as well as 6–8,
consistently identified food-allergic patients (both
IgE-mediated and non-IgE-mediated) with excel-
lent discrimination from non-food allergic controls
(sensitivity 100%; specificity 100%), and being a
“percentage of agreement” indicator. Further-
more, item 8 (“How long after food ingestion did
the reactions appear?“) also discriminated be-
tween patients with confirmed classical IgE-
mediated food allergy (all had reactions in less
than 2 h after food ingestion) and patients with
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Table 3. Temporal Stability for Relevant questions by sex, age, time in
Spearman's Rho for each different subgroupmore than 2 h after food ingestion) with high
sensitivity (100%) and specificity (100%).
Test-retest reliability (temporal stability)
In the case-control validation cluster groups
(IgE- and non-IgE-mediated analysed together),
mean re-application time value was 7  9 weeks
(range: 2–38 weeks; median and mode: 2 weeks).
In the control group, mean re-application time was
8  7 weeks (range: 2–34 weeks; median and
mode: 2 weeks), thereby allowing analysis of the
variability of replies to each of the items of the
questionnaire. Temporal stability was calculated by
determining Spearman's Rho correlation coeffi-
cient for 8 items (items number 5, 9, 11–15, 17)
which were regarded as indispensable, since they
objectively characterized the development of
adverse food reactions, and due to the “yes-no”
binary answer type. The set of 8 previously
mentioned items, both globally and also taking
gender, age, time interval between test and retest,
as well as the volunteers' source of referral (diag-
nosed patients and Health Care Centres) into ac-
count are shown in Table 3. Five patients had new
reactions between test and re-test phases, byclasses Rho spearman'svalues p value (*)
0.927 p < 0.001
0.898 p < 0.001
0.724 p < 0.001
0 0.986 p < 0.001
0.713 p < 0.001
0.947 p < 0.001
0.614 p < 0.010
0.500 p < 0.050
0.489 p < 0.100
ients 0.667 p < 0.001
care Centre #1 0.733 p < 0.010
care Centre #2 0.450 p < 0.100
care Centre #3 0.758 p < 0.001
terval and local origin. (*) p value indicates statistical significance of
Volume 13, No. 9, Month 2020 9inadvertent ingestion of suspect foods or ingestion
by self-initiative to see whether they could tolerate
the foods. No differences were found in temporal
stability when sex, age, and volunteer origin were
analysed. An inverse relationship was found be-
tween reliability and retest time interval.DISCUSSION
In the present study, we developed and ana-
lysed in terms of face, content and construct
(known-group) validity and reliability (temporal
stability), for the first time in the Portuguese lan-
guage, a screening questionnaire of adverse food
reactions in the general adult population. This
questionnaire was rapid and easily applicable, and
showed excellent known-group validity, as well as
a high degree of temporal stability. On the other
hand, there was no variability in results when
gender, age, and extra-hospital referral source of
the volunteers were taken into account. In addi-
tion, Spearman's Rho correlation coefficient did
not show significant differences across health care
centres where control, non-food allergic volun-
teers were recruited.
Although, after the pilot study, we only analysed
138 volunteers (60 randomly selected non-food
allergic controls, 64 patients with confirmed IgE-
mediated food allergies, and 12 patients with
confirmed non-IgE-mediated food allergies), this
number is well within what is accepted as an
appropriate sample size for this type of studies.23
For the assessment of the questionnaire, we
studied reproducibility (test-retest stability) of the
questionnaire, which was very high in global terms,
as expressed in Spearman's Rho values of 0.80.
Furthermore, reproducibility of specific items
showed Cohen's Kappa values greater than 0.80
for most items, which is very good given the
number of analysed items.22,28 However, again
items 12: “time elapsed since the previous
episode”, 11:"existence previous episodes of
food allergy”, item 15: “personal history of atopy”
and 17: “Would you want to be followed up at
specialty clinic?” significantly varied with time,
between test and retest. This may have been due
to memory bias, as reported by other studies,29
or may have been due to the fact that volunteers
might not be aware of the co-existence of otherallergic diseases in them or did not report them
either during test or re-test phase. In addition, in
the case of item 12, discrepancy may arise from
the fact that adverse food reactions may develop
between test and retest, as a result of accidental
exposure30,31 or as self-initiative to test a minor
portion of food, as actually happened in a small
proportion of the patients (n ¼ 5) in our study, or
inversely by development of tolerance, which was
unlikely in our study, given the short period of time
between test and re-test.32 In addition, volunteers
with food allergies may develop novel reactions to
new foodstuffs not mentioned in the first test, as
may happen with patients sensitised to various
food families (fruits, fish, seafood, egg, milk,
etc)30,33 thereby potentially affecting items 11
and 12.
Low temporal stability was found for items 15
and 17, (“Do you have any other allergic disease?”
and “Would you want to be followed up at spe-
cialty clinic?”), with a value for Cohen's Kappa of
0.441 and 0.296 respectively (Table 4). This may
have been due to the fact that a proportion of
patients either became aware that they had an
allergic disease or had a confirmed diagnosis of
allergic disease between test and retest, as was
observed in some cases. On the other hand,
since food allergic patients were already being
followed up at a clinic and the remainder of the
volunteers were non-food allergic, this may have
been associated with confusion regarding the
need to be re-evaluated. In fact, non-food allergic
volunteers who changed their answers between
test and re-test, had mild symptoms they inter-
preted as possible rhinitis, conjunctivitis or
dermatitis, which waxed and waned, which may
have been associated with such changes in an-
swers to item 17. Finally, the low temporal stability
may also have been due to a memory bias as
previously referred, since it was not possible to
analyse this item separately from the variability
between groups (non-food allergic controls versus
patients with food allergies) using Spearman's
coefficient, given the relatively limited size of the
sample. In spite of these aforementioned factors
potentially affecting the “8 crucial questions”
(items 5,9,11–15,17), 6 of these questions main-
tained an optimal degree of temporal stability




Cohen's Kappa Value (Test-ReTest
reliability: intraclass correlation)
5 Do you have any adverse food reaction? 0.914
9 Did you have medical treatment? 0.830
11 Have you had any previous episodes with the
same food?
0.696
12 How long ago did the previous reaction take
place?
0.641
13 Have you been previously diagnosed a food
allergy?
0.886
14 Have you ever been to a specialty appointment
by an Allergist doctor?
0.892
15 Do you have any other allergic disease? 0.441
17 Would you want to be followed up at specialty
clinic?
0.296
Table 4. Analysis of temporal stability (test- Re-test reliability). p < 0.05 for all values
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retested within 2 weeks of the initial test, there was
high amplitude of time intervals, with a few of the
patients being retested after 30 weeks. We
acknowledge that this may be a limitation of our
study since current guidelines for the performance
of this type of study state that the ideal interval
should be between 4 weeks and 6 months (ideally
between 15 and 45 days).34–36 Nevertheless, our
study followed COSMIN guidelines,37 and
allowed the study of reliability (internal
consistency and some aspects of reliability).
One important feature of our screening ques-
tionnaire is the fact that it is short and quick to
apply. This is highly relevant to its application in
clinical settings as well as in studies involving large
samples, since it has been shown that volunteers’
attention time span decreases as the length of a
questionnaire increases.38 In addition, our
questionnaire adequately discriminated patients
with confirmed food allergies from those without
food allergies. It also discriminated between
patients with IgE-mediated food allergies
(n ¼ 22, for the intelligility phase and n ¼ 66 for the
other validity assessment phases) from those with
non-IgE-mediated food allergies (n ¼ 12), on the
basis of item 8, regarding timing of development
of reactions upon food ingestion. However, the
latter group only included 12 patients, which is alimitation of our study, and we are also aware that
some patients with non-IgE-mediated food al-
lergies may also have early onset symptoms.
Our study had other limitations. Firstly, it is a
pilot study that needs a larger sample to improve
its performance, applicability, and generalizability.
Although, based on the sociodemographic fea-
tures of our samples of patients and controls, we
believe that these were representative of the Por-
tuguese population for the age range in question,
we still have to adequately study its generalizability
to other Portuguese speaking countries. Secondly,
although we used the acknowledge known-groups
validity with 2 groups of food-allergic patients (IgE-
and non-IgE-mediated) and 1 group of non-food
allergic individuals to assess construct validity,
due to the type of questions being asked, and the
format of replies, it was not possible to carry out
factor analysis or internal stability procedures. In
addition, our questionnaire needs to be further
studied with a higher sample, in terms of its limits
for discriminating between classical IgE-mediated
and non-IgE-mediated food allergies.
In spite of the limitations, our study also has new
and consistent results. Firstly, our results do suggest
that this screeningquestionnaire is essentially useful
for screening of food allergies in cross-sectional
studies but may need to be optimized for the
Volume 13, No. 9, Month 2020 11follow-up of patients over time. Furthermore, this
questionnaire is the first one developed and vali-
dated in the Portuguese language for adults with
food allergies, and we believe it may be applied in
all Portuguese speaking countries worldwide (250
million people). In addition, our questionnaire is
simple and quickly applicable and also fully based
upon accepted criteria for a sensitive collection of
the clinical history of food allergies.39,40 We also
believe that it is easily adaptable to other
languages, particularly because not many clinical
screening questionnaires are available for the
study of adverse food reactions as an initial
approach to the investigation of food allergy in
adults. Our study was an alternative to the
validation, in Portuguese, of the clinical history
section of the EuroPrevall questionnaires and one
of our future projects will be to assess the validity
of our questionnaire in comparison with such
EuroPrevall approach, regarded as a quality
reference.
In conclusion, we developed, for the first time in
the Portuguese language, a screening question-
naire for the study of adverse food reactions in
adults, which showed high reproducibility and
good potential to be a useful screening test in
potentially different settings.Consent for publication
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